Loading quotes...
Forecast
There is no analyst data available for this company.
News Go to news feed
There is currently no news available for this company. We are working on adding more providers to change this.
Financials
| (EUR) | 2023 | YoY |
|---|---|---|
| Revenue | 78.57k | 135.30% |
| Gross profit | 48.43k | 131.37% |
| Net profit | -3.87m | 44.08% |
| EBITDA | 3.9m | 129,500.08% |
Fundamentals
| Metric | Value |
|---|---|
Market capitalization | €2.68m |
Number of shares | 602.25m |
52-week high/low | €0.0239 - €0.00299 |
| Dividends | No |
Beta | -1.39 |
P/E ratio | -0.42 |
PEG ratio | 0.00 |
P/B ratio | 1.46 |
P/S ratio | 45.43 |
Company profile
Cellular Goods PLC, together with its subsidiaries, manufactures and sells biosynthetic cannabinoids-based consumer products in the United Kingdom. The company provides cannabinoid solutions for skincare and ingestible products. It offers its products through retailers; direct to consumers through its website; and online. The company was formerly known as Leaf Studios PLC and changed its name to Cellular Goods PLC in September 2020. Cellular Goods PLC was incorporated in 2018 and is based in London, United Kingdom.
| Name | CELLULAR GOODS LS -,0001 |
| CEO | Bruna Nikolla |
| Headquarters | London,
United Kingdom |
| Website | |
| IPO | 26/02/2021 |
| Employees | 5 |
Deep Dive
Ticker symbols
| Exchange | Symbol |
|---|---|
London Stock Exchange | CBX.L |
Frankfurt | 6XS.F |
London | CBX.L |
München | 6XS.MU |